New analysis shows that overdue utility balances averaged $789 (£600) by June 2025, with almost 14 million Americans in ...

Predictive Oncology (Nasdaq: POAI), an AI-driven drug discovery company that has expanded its business to include a digital asset str ...

Revenue of $2.8 Million for Q3 2025, up 163% from Q3 2024Gross Profit of $2.3 Million for Q3 2025, a 213% increase from Q3 2024; Gross Margin ...

The latent profile analysis was used to identify the self-efficacy groups of young and middle-aged patients with aortic ...

Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, ...

Record quarterly revenue of $1.11 million, an increase of 32% sequentially and 28% year-over-year, driven by consumable cartridge sales and ...